Kymriah® (tisagenlecleucel) - An overview of the clinical development journey of the first approved CAR-T therapy

Awasthi, R; Maier, HJ; Zhang, J; Lim, S

Awasthi, R (通讯作者),Novartis Inst Biomed Res, Oncol & Hematol, One Hlth Plaza, E Hanover, NJ 07936 USA.

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023; 19 (1):

Abstract

The emergence of cell and gene therapies has dramatically changed the treatment paradigm in oncology and other therapeutic areas. Kymriah (R) (tisagen......

Full Text Link